Currently, no company worldwide has completed the required oral toxicity studies, metabolism studies, and long-term safety evaluations for GHK-Cu and submitted a GRAS notification to the FDA
It is intended for use in studies involving metabolic flexibility and the quantification of energy substrate utilization within muscle tissue
This article was submitted to Experimental Pharmacology and Drug Discovery, a section of the journal Frontiers in Pharmacology
Where can researchers source KLOW peptide
Dose: SC injection of 250 g per injection in cats and, 250-1500 g per injection in dogs, depending on the size of the patient: *Information provided by Texas GI Lab* Northland Veterinary Services8560 Topper RoadIron River, WI 54847(715)372-5590
However, little high-level clinical trial evidence has been published on the use of molecular hydrogen to treat liver disease, and some studies are still being registered